Literature DB >> 15709356

The antimicrobial activity of maggots: in-vivo results.

P Steenvoorde1, G N Jukema.   

Abstract

In the literature maggot therapy is discussed as a promising and potent form of debridement therapy. The number of maggots needed to debride a wound is estimated at 10 per cm2, and more in case of a higher percentage of necrosis or slough. In the authors' hospital, from March 1999 to May 2002, 16 patients were successfully treated with maggot therapy. The average maggot treatment time was 27 days, with an average of seven maggot changes. Most patients were treated for osteomyelitis, with trauma being the leading aetiological factor. In accordance with in-vitro findings, maggot therapy was found to be more effective in gram-positive infected wounds. Gram-negative bacteria are cultured more often after maggot treatment than before it (p=0.001). The opposite effect was found for gram-positive infected wounds (non-significant p=0.07). In vivo maggots seem to be less effective against gram-negative infected wounds. The authors believe that a higher number of maggots is needed not only for a larger wound or a wound with a higher percentage covered with slough, but also for a wound infected with gram-negative bacteria.

Entities:  

Mesh:

Year:  2004        PMID: 15709356     DOI: 10.1016/s0965-206x(04)43005-8

Source DB:  PubMed          Journal:  J Tissue Viability        ISSN: 0965-206X            Impact factor:   2.932


  20 in total

1.  Crude extract of maggots: antibacterial effects against Escherichia coli, underlying mechanisms, separation and purification.

Authors:  Quan-Sheng Ge; Hui-Min Zhang; Xia Liu; Shou-Yu Wang; De-Cheng Lv; Xu-Dong Li
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 2.  Maggot therapy takes us back to the future of wound care: new and improved maggot therapy for the 21st century.

Authors:  Ronald A Sherman
Journal:  J Diabetes Sci Technol       Date:  2009-03-01

3.  Maggot debridement therapy of infected ulcers: patient and wound factors influencing outcome - a study on 101 patients with 117 wounds.

Authors:  Pascal Steenvoorde; Cathrien E Jacobi; Louk Van Doorn; Jacques Oskam
Journal:  Ann R Coll Surg Engl       Date:  2007-09       Impact factor: 1.891

4.  A novel approach to the antimicrobial activity of maggot debridement therapy.

Authors:  Anders S Andersen; Dorthe Sandvang; Kirk M Schnorr; Thomas Kruse; Søren Neve; Bo Joergensen; Tonny Karlsmark; Karen A Krogfelt
Journal:  J Antimicrob Chemother       Date:  2010-06-11       Impact factor: 5.790

Review 5.  Traditional Therapies for Skin Wound Healing.

Authors:  Rúben F Pereira; Paulo J Bártolo
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-05-01       Impact factor: 4.730

6.  The influence of maggot excretions on PAO1 biofilm formation on different biomaterials.

Authors:  Gwendolyn Cazander; Kiril E B van Veen; Lee H Bouwman; Alexandra T Bernards; Gerrolt N Jukema
Journal:  Clin Orthop Relat Res       Date:  2008-10-16       Impact factor: 4.176

7.  Maggot secretions suppress pro-inflammatory responses of human monocytes through elevation of cyclic AMP.

Authors:  M J A van der Plas; M Baldry; J T van Dissel; G N Jukema; P H Nibbering
Journal:  Diabetologia       Date:  2009-07-03       Impact factor: 10.122

8.  Quorum-sensing-regulated virulence factors in Pseudomonas aeruginosa are toxic to Lucilia sericata maggots.

Authors:  A S Andersen; B Joergensen; T Bjarnsholt; H Johansen; T Karlsmark; M Givskov; K A Krogfelt
Journal:  Microbiology (Reading)       Date:  2009-11-05       Impact factor: 2.777

Review 9.  Complement activation and inhibition in wound healing.

Authors:  Gwendolyn Cazander; Gerrolt N Jukema; Peter H Nibbering
Journal:  Clin Dev Immunol       Date:  2012-12-30

10.  Excretions/secretions from bacteria-pretreated maggot are more effective against Pseudomonas aeruginosa biofilms.

Authors:  Ke-chun Jiang; Xin-juan Sun; Wei Wang; Lan Liu; Ying Cai; Yin-chen Chen; Ning Luo; Jian-hua Yu; Da-yong Cai; Ai-ping Wang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.